Literature DB >> 9463798

Linkage of autosomal recessive primary congenital glaucoma to the GLC3A locus in Roms (Gypsies) from Slovakia.

M Plásilová1, E Feráková, L Kádasi, H Poláková, A Gerinec, J Ott, V Ferák.   

Abstract

The autosomal recessive form of primary congenital glaucoma (gene symbol GLC3) has been recently mapped to two different loci, GLC3A (at 2p21), and GLC3B (at 1p36), respectively, on families of Turkish and Saudi Arabian provenance. This disorder is known to occur with an extremely high incidence in Roms (Gypsies) in Slovakia. We performed a standard linkage analysis on a sample of 7 Slovak Gypsy families comprising 18 affected members, and found significant linkage with four STR markers from the chromosomal region of 2p21 (D2S1788, D2S1346, D2S2328, and D2S1356), without heterogeneity. This finding demonstrates that in the Rom population of Slovakia, primary congenital glaucoma is due to the locus GLC3A, and consequently, to the mutation(s) in the cytochrome P4501B1 gene, which has been recently identified as the principal cause of the disease. Roms represent the third population, in which the disorder has been mapped to GLC3A.

Entities:  

Mesh:

Year:  1998        PMID: 9463798     DOI: 10.1159/000022778

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  16 in total

1.  Statistical approaches to gene mapping.

Authors:  J Ott; J Hoh
Journal:  Am J Hum Genet       Date:  2000-07-06       Impact factor: 11.025

2.  Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma.

Authors:  M Plásilová; I Stoilov; M Sarfarazi; L Kádasi; E Feráková; V Ferák
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

Review 3.  Family-based designs for genome-wide association studies.

Authors:  Jurg Ott; Yoichiro Kamatani; Mark Lathrop
Journal:  Nat Rev Genet       Date:  2011-06-01       Impact factor: 53.242

4.  Disease-causing mutations in proteins: structural analysis of the CYP1B1 mutations causing primary congenital glaucoma in humans.

Authors:  Malkaram S Achary; Aramati B M Reddy; Subhabrata Chakrabarti; Shirly G Panicker; Anil K Mandal; Niyaz Ahmed; Dorairajan Balasubramanian; Seyed E Hasnain; Hampapathalu A Nagarajaram
Journal:  Biophys J       Date:  2006-09-08       Impact factor: 4.033

5.  Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1.

Authors:  I Stoilov; A N Akarsu; I Alozie; A Child; M Barsoum-Homsy; M E Turacli; M Or; R A Lewis; N Ozdemir; G Brice; S G Aktan; L Chevrette; M Coca-Prados; M Sarfarazi
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Molecular characterisation of congenital glaucoma in a consanguineous Canadian community: a step towards preventing glaucoma related blindness.

Authors:  S N Martin; J Sutherland; A V Levin; R Klose; M Priston; E Héon
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

7.  A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23.

Authors:  T Rogers; D Chandler; D Angelicheva; P K Thomas; B Youl; I Tournev; V Gergelcheva; L Kalaydjieva
Journal:  Am J Hum Genet       Date:  2000-07-27       Impact factor: 11.025

8.  CYP1B1, MYOC, and LTBP2 mutations in primary congenital glaucoma patients in the United States.

Authors:  Sing-Hui Lim; Khanh-Nhat Tran-Viet; Tammy L Yanovitch; Sharon F Freedman; Thomas Klemm; Whitney Call; Caldwell Powell; Ajay Ravichandran; Ravikanth Metlapally; Erica B Nading; Steve Rozen; Terri L Young
Journal:  Am J Ophthalmol       Date:  2012-12-04       Impact factor: 5.258

9.  Primary Congenital Glaucoma and the Involvement of CYP1B1.

Authors:  Kiranpreet Kaur; Anil K Mandal; Subhabrata Chakrabarti
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

10.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.